Applicant, as named in the Orange Book

Xeris

Next listed expiry: Gvoke Hypopen on 22 Apr 2036. 3 products with live protection, 1 without.

Products with listed protection

Drug	Ingredient	Earliest generic entry	Basis
Gvoke Hypopen NDA 212097 · 2 strengths glucagon	glucagon	22 Apr 2036 patent	patent
Gvoke Kit NDA 212097 glucagon	glucagon	22 Apr 2036 patent	patent
Gvoke Pfs NDA 212097 glucagon	glucagon	22 Apr 2036 patent	patent

Daranide · Generic approved · ANDA 218783, RisingApproved 18 Nov 2025Detected 25 Oct 2026

Products without listed protection (1)

Drug	Ingredient	Earliest generic entry	Basis
Keveyis NDA 011366 dichlorphenamide	dichlorphenamide	open now no listed protection	no listed protection